Overview
Ensign Q3 adjusted revenue grows 19.8%, beating analyst expectations
Adjusted EPS for Q3 rises 18% yr/yr, exceeding analyst estimates
Company raises 2025 earnings guidance to $6.48-$6.54 per share
Outlook
Ensign raises 2025 earnings guidance to $6.48-$6.54 per share
Company increases 2025 revenue guidance to $5.05 bln-$5.07 bln
Ensign cites strong demographic trends as a tailwind for growth
Result Drivers
OCCUPANCY GROWTH - Ensign reports record occupancy rates in same and transitioning facilities, attributed to strong clinical outcomes and market share gains
REVENUE INCREASE - Skilled services revenue increased by 19.9%, driven by higher occupancy and skilled mix in same and transitioning facilities
ACQUISITION STRATEGY - Ensign's acquisition of 22 new operations, including 10 real estate assets, contributed to revenue growth
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Rental Revenue
$6.62 mln
Q3 Adjusted Revenue
Beat
$1.30 bln
$1.27 bln (5 Analysts)
Q3 Adjusted EPS
Beat
$1.64
$1.57 (5 Analysts)
Q3 EPS
$1.42
Q3 Net Income
$83.91 mln
Q3 Operating Income
$96.21 mln
Q3 Service Revenue
$1.28 bln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Ensign Group Inc is $185.00, about 2.6% above its October 31 closing price of $180.10
The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 22 three months ago
Press Release: ID:nGNX3nw7JR
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)